Retatrutide 10mgLAB TEST JAN/2025 99.49% – IN STOCK

$160.00

In stock

Triple-Hormone-Receptor Agonist Retatrutide for Obesity

Acknowledgment Required: Please understand these products do affect blood sugar levels, and please be cautious of the dose you take. We strongly advise conducting thorough research on proper dosing and consulting a medical professional before use. Our products are intended solely for research and testing purposes.

RETATRUTIDE 10MG – NEXT-GENERATION WEIGHT LOSS & METABOLIC ENHANCER

RETATRUTIDE is a multi-receptor agonist that combines GLP-1, GIP, and glucagon activation for superior weight loss, metabolic control, and appetite suppression. Designed for obesity management and blood sugar regulation, this cutting-edge therapy helps burn fat, improve insulin sensitivity, and enhance energy balance, making it a breakthrough option for those seeking effective body composition changes.

The Details:

  • Dosage: 10mg per injection
  • Administration: Subcutaneous injection (typically once weekly)
  • Source: Pharmaceutical-grade formulation for metabolic health and weight management

Key Features:

✔ Advanced Weight Loss Support – Enhances fat-burning and appetite control
✔ Triple Hormone Action – Activates GLP-1, GIP, and glucagon for enhanced metabolic effects
✔ Blood Sugar Regulation – Improves insulin sensitivity and glucose metabolism
✔ Lean Body Mass Preservation – Promotes fat loss while maintaining muscle
✔ Once-Weekly ConvenienceLong-acting formula for sustained results

Safety Guidelines:

  • Gradual Dose Adjustment Recommended – To minimize gastrointestinal side effects
  • Not for Use in Certain Conditions – Consult a doctor if you have thyroid or pancreatic issues

Legal Disclaimer:

This product is for prescription use only and should be taken under medical supervision. The information provided is for educational purposes and does not replace professional medical advice. Always consult a healthcare provider before using Retatrutide.

Main Menu

Retatrutide 10mgLAB TEST JAN/2025 99.49% - IN STOCK